GENEREX BIOTECHNOLOGY CORP Uncategorized Contracts & Agreements
72 Contracts & Agreements
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 3, 2020)
- NOTESETTLEMENT AGREEMENT (Filed With SEC on August 11, 2020)
- WiringInstructions: SignatureBank 565Fifth Avenue NewYork, New York 10017 Routing#: 026013576 Account#: 1502765147 AccountTitle: Carmel, Milazzo & Feil LLP (Filed With SEC on June 22, 2020)
- APPENDIXA- Statement of Work (Filed With SEC on June 8, 2020)
- LaboratoryServices AGreement (Filed With SEC on June 8, 2020)
- X = Y (A-B) A (Filed With SEC on February 18, 2020)
- Exhibit 3 Transfer Agent Instructions GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 18, 2020)
- WHEREAS: (Filed With SEC on February 18, 2020)
- AMENDMENT AGREEMENT (Filed With SEC on January 28, 2020)
- AGREEMENT: (Filed With SEC on July 16, 2019)
- RECITALS: (Filed With SEC on July 16, 2019)
- RESTRUCTURING AGREEMENT (Filed With SEC on April 4, 2019)
- BACKGROUND (Filed With SEC on February 22, 2019)
- AMENDMENT AGREEMENT (Filed With SEC on January 22, 2019)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 3, 2018)
- SignaturePage to Follow (Filed With SEC on December 3, 2018)
- STOCKCONTROL AGREEMENT (Filed With SEC on December 3, 2018)
- SignaturePage to Follow (Filed With SEC on November 30, 2018)
- ClinicalTrial Agreement PHASEII STUDY between NSABPFoundation, Inc. and AntigenExpress, Inc. (Filed With SEC on November 26, 2018)
- PROMISORRYNOTE DUEJANUARY 15, 2019 (Filed With SEC on November 5, 2018)
- AMENDMENT to ASSETPURCHASE AGREEMENT (Filed With SEC on November 5, 2018)
- STOCKPLEDGE AGREEMENT (Filed With SEC on October 26, 2018)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 26, 2018)
- STOCKOPTION AGREEMENT (Filed With SEC on October 9, 2018)
- PROMISSORYNOTE (Filed With SEC on October 9, 2018)
- ASSETPURCHASE AGREEMENT (Filed With SEC on October 9, 2018)
- LICENSEAND RESEARCH AGREEMENT BETWEEN ANTIGENEXPRESS, INC. (AWHOLLY-OWNED SUBSIDIARY OF GENEREXBIOTECHNOLOGY CORPORATION) AND SHENZHENBIOSCIEN PHARMACEUTICALS CO. LTD.... (Filed With SEC on December 12, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 29, 2017)
- CONVERTIBLENOTE DUEMARCH ____, 2018 (Filed With SEC on March 6, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 6, 2017)
- RIGHTTO SHARES AGREEMENT (Filed With SEC on February 15, 2017)
- PRIVATE ANDCONFIDENTIAL (Filed With SEC on January 20, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 25, 2015)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
- OPTION AGREEMENT (Filed With SEC on December 9, 2013)
